Loading stock data...

Kerala Ayurveda Limited

BSE: KERALAYUR

BSE
217.65 -1.30 (-0.59%)

Prev Close

218.95

Open Price

226.85

Volume

3,167

Today Low / High

213.3 / 226.85

52 WK Low / High

213.3 / 625

Range

207 - 229

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 217.65, reflecting a change of -1.3 (-0.59374%). The expected target range on the BSE is 207 - 229. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 226.85 -4.03%
24 Feb 225.20 -2.78%
23 Feb 238.00 -5.38%
20 Feb 239.50 -4.78%
19 Feb 235.80 -1.93%
18 Feb 226.60 2.21%
17 Feb 231.95 -1.83%
16 Feb 234.55 -3.62%
13 Feb 241.90 -3.04%
12 Feb 248.90 -2.79%
11 Feb 251.80 -1.83%
10 Feb 253.90 -1.79%
09 Feb 252.00 -1.61%
06 Feb 247.00 1.13%
05 Feb 244.05 -0.08%
04 Feb 247.40 -0.02%
03 Feb 235.90 3.12%
02 Feb 240.30 -5.08%
01 Feb 257.35 -4.60%
30 Jan 264.00 -2.16%
29 Jan 263.75 -1.82%
28 Jan 250.40 4.81%

Kerala Ayurveda Limited Graph

Kerala Ayurveda Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Kerala Ayurveda Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 217.65, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 217.65 219.83 197.84 - 241.81
222.00 177.60 - 266.40
224.18 156.93 - 291.43
Bearish Scenario 217.65 215.47 193.93 - 237.02
213.30 170.64 - 255.96
211.12 147.78 - 274.46

Overview of Kerala Ayurveda Limited

ISIN

INE817B01025

Industry

Medical - Pharmaceuticals

Vol.Avg

13,334

Market Cap

2,629,123,164

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

318.74

DCF

-103

Financial Ratios Every Investor Needs

Stock Rating Details for KERALAYUR

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 120.33 Cr 81.94 Cr 38.39 Cr 0.3191 0.00 Cr 14.29 Cr -9.97 Cr -14.70 Cr -12.56 -3.17 Cr -0.1222
2024-03-31 102.34 Cr 57.57 Cr 44.77 Cr 0.4375 0.76 Cr 7.06 Cr 4.80 Cr -1.53 Cr -1.38 7.08 Cr -0.0149
2023-03-31 93.05 Cr 20.05 Cr 34.73 Cr 0.3733 0.36 Cr 6.24 Cr 5.01 Cr -0.90 Cr -0.85 5.74 Cr -0.0097
2022-03-31 80.00 Cr 17.17 Cr 33.65 Cr 0.4206 0.12 Cr 4.64 Cr 9.86 Cr 2.36 Cr 2.24 10.67 Cr 0.0295
2021-03-31 61.87 Cr 15.33 Cr 46.54 Cr 0.7523 0.08 Cr 3.62 Cr 19.97 Cr -4.84 Cr -4.59 0.86 Cr -0.0783

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3.39 Cr 128.76 Cr 115.87 Cr 9.4935 Cr 70.66 Cr 67.27 Cr 12.96 Cr 40.28 Cr 0.00 Cr 0.00 Cr 26.99 Cr 87.9750 Cr
2024-03-31 22.79 Cr 140.90 Cr 105.76 Cr 32.1636 Cr 67.58 Cr 44.78 Cr 15.50 Cr 30.72 Cr 0.00 Cr 0.00 Cr 25.26 Cr 40.4043 Cr
2023-03-31 4.38 Cr 115.90 Cr 108.02 Cr 5.5758 Cr 73.62 Cr 69.24 Cr 12.49 Cr 30.84 Cr 14.41 Cr 0.00 Cr 17.95 Cr 52.6938 Cr
2022-03-31 2.87 Cr 110.24 Cr 102.30 Cr 6.1098 Cr 91.96 Cr 89.15 Cr 11.97 Cr 26.10 Cr 11.69 Cr 0.00 Cr 17.78 Cr 60.2929 Cr
2021-03-31 18.56 Cr 114.49 Cr 109.28 Cr 3.4034 Cr 78.95 Cr 60.39 Cr 11.00 Cr 35.80 Cr 9.59 Cr 0.00 Cr 17.33 Cr 41.9202 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.7463 Cr -14.7685 Cr -5.3981 Cr -12.5819 Cr -19.4058 Cr 3.3891 Cr -13.3282 Cr -14.6991 Cr -5.3980 Cr 0.0000 Cr -0.6883 Cr
2024-03-31 -2.2673 Cr -0.4536 Cr 19.8333 Cr -3.3807 Cr 18.4158 Cr 22.7949 Cr -1.1134 Cr -1.5271 Cr -6.0452 Cr 0.0000 Cr -3.0064 Cr
2023-03-31 9.8579 Cr -7.2181 Cr -1.1350 Cr 3.6755 Cr 1.5048 Cr 4.3791 Cr -6.1825 Cr 4.2629 Cr 3.6870 Cr 0.0000 Cr -0.5188 Cr
2022-03-31 -0.5017 Cr -1.9091 Cr -13.2744 Cr -3.3509 Cr -15.6852 Cr 2.8743 Cr -2.8492 Cr 9.3245 Cr -6.7546 Cr 0.0000 Cr -0.9713 Cr
2021-03-31 7.4277 Cr -1.4395 Cr 6.2039 Cr 6.3855 Cr 12.1922 Cr 18.5595 Cr -1.0422 Cr -0.4163 Cr 12.5259 Cr 0.0000 Cr 1.8269 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 32.96 Cr 21.06 Cr 11.90 Cr 0.3611 -2.66 Cr -4.45 Cr -3.69 -1.51 Cr -0.1349
2025-09-30 34.84 Cr 10.12 Cr 24.72 Cr 0.7096 -5.94 Cr -6.34 Cr -7.23 -3.25 Cr -0.1819
2025-06-30 28.61 Cr 6.97 Cr 21.64 Cr 0.7565 -5.84 Cr 1.99 Cr 1.92 5.29 Cr 0.0695
2025-03-31 32.05 Cr 5.59 Cr 26.46 Cr 0.8257 7.13 Cr -15.54 Cr -13.68 -10.09 Cr -0.4848
2024-12-31 31.13 Cr 5.58 Cr 25.55 Cr 0.8207 -1.92 Cr -2.89 Cr -2.40 -0.95 Cr -0.0929

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 4.91 Cr 0.96 Cr 5.87 Cr 16.54 Cr 16.70 Cr 48.62 Cr 40.53 Cr 135.46 Cr 126.45 Cr
2025-06-30 0.00 Cr 0.00 Cr 3.39 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -12.89 Cr
2025-03-31 3.39 Cr 0.00 Cr 3.39 Cr 19.30 Cr 12.96 Cr 40.77 Cr 40.28 Cr 128.76 Cr 115.87 Cr
2024-12-31 0.00 Cr 0.00 Cr 7.49 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -39.39 Cr
2024-09-30 7.49 Cr 0.00 Cr 7.49 Cr 19.19 Cr 13.78 Cr 49.20 Cr 33.47 Cr 138.67 Cr 99.27 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -14.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -2.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 3.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.32 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2006-04-28 April 28, 06 551:1000

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹854.80 ₹102,578,890,079.00 ₹242,213.00

Key Executives

Whole Time Director
Kunjupanicker Anilkumar

Gender: Not Specified

Year Born: 1954

Chief Financial Officer
K. T. George

Gender: male

Year Born: 1977

Chief Commercial Officer
Paul Varghese

Gender: male

Year Born:

Chief Strategy & Transformation Officer
Rakesh Kumar Roy

Gender: male

Year Born:

Chief Business Officer
Sripath Hariharan

Gender: male

Year Born:

Chief Executive Officer
Vivek Sunder

Gender: male

Year Born:

Company Secretary & Compliance Officer
Priyanka Gangwar

Gender: female

Year Born:

Chief Product & Tech Officer
Utkarsh Mishra

Gender: male

Year Born:

FAQs about Kerala Ayurveda Limited

Who is the CEO of the company?

The CEO is Vivek Sunder.

What is the current market price of the stock?

The current price is ₹218.00.

What is the 52-week price range?

The range is ₹213.3-625.

What is the market capitalization of the company?

The market capitalization is ₹262.91 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -10.81.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Kerala Ayurveda Limited (ISIN: INE817B01025) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹262.91 crores and an average daily volume of 13,334 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.